Premavision Cohort Follow-up
Not Applicable
Terminated
- Conditions
- Visual Disorder
- Interventions
- Diagnostic Test: Visual acuity measurement
- Registration Number
- NCT03207477
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
This study aim at following a cohort of prematurely born infants at 18 months corrected age, 4 and 7 years of age. This cohort had an evaluation of visual maturation at term equivalent age (TEA) with factors associated with impaired visual maturation. (PREMAVISION-CLinicalTrials.gov ID: NCT02890251).
In this follow-up study, prematurely born infants vision will be compared to term born infants matched for postnatal age.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
- Infants included in the Premavision cohort
- Term born healthy control infants at matched postnatal age
Exclusion Criteria
- Ocular malformation
- Genetic abnormality
- Neurodevelopmental impairment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Prematurely born infants Visual acuity measurement Visual acuity measurement in prematurely born infants included in PREMAVISION study Term born infants Visual acuity measurement Visual acuity measurement in term born control infants
- Primary Outcome Measures
Name Time Method Visual acuity measurement 7 years post-natal age Parinaud and Snellen tests
- Secondary Outcome Measures
Name Time Method Measurement of cyclopegic refraction 7 years of age Non invasive refraction measurement by autorefractometer
Trial Locations
- Locations (1)
Maternity Hospital CHRU
🇫🇷Nancy, France